PT - JOURNAL ARTICLE AU - Colin J. Carlson AU - Rita Colwell AU - Mohammad Sharif Hossain AU - Mohammed Mofizur Rahman AU - Alan Robock AU - Sadie J. Ryan AU - Mohammad Shafiul Alam AU - Christopher H. Trisos TI - Solar geoengineering could redistribute malaria risk in developing countries AID - 10.1101/2020.10.21.20217257 DP - 2020 Jan 01 TA - medRxiv PG - 2020.10.21.20217257 4099 - http://medrxiv.org/content/early/2020/10/25/2020.10.21.20217257.short 4100 - http://medrxiv.org/content/early/2020/10/25/2020.10.21.20217257.full AB - Solar geoengineering is often framed as a stopgap measure to decrease the magnitude, impacts, and injustice of climate change. However, the costs or benefits of geoengineering for human health are largely unknown. We project how geoengineering could impact malaria risk by comparing transmission suitability and populations-at-risk today against moderate and high emissions scenarios (RCP 4.5 and 8.5) with and without geoengineering over the next half-century. We show that if geoengineering deployment cools the tropics, it could help protect high elevation populations in eastern Africa from the encroachment of malaria, but could increase transmission in lowland sub-Saharan Africa and southern Asia. Compared to extreme warming, we also find that by 2070, geoengineering would nullify a projected reduction of nearly one billion people at risk of malaria. Our results indicate that geoengineering strategies designed to offset warming are not guaranteed to unilaterally improve health outcomes, and could produce regional trade-offs among Global South countries that are often excluded from geoengineering conversations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by funding from the Solar Radiation Management Governance Initiative (SRMGI) Developing Country Impacts Modelling Analysis for Solar Radiation Management (DECIMALS) grant program. CHT was supported by the FLAIR Fellowship Programme: a partnership between the African Academy of Sciences and the Royal Society funded by the UK Government's Global Challenges Research Fund. Alan Robock supported by NSF grants AGS-1617844 and AGS-2017113. icddr,b is grateful to the Government of Bangladesh, Canada, Sweden, and the UK for providing core/unrestricted support.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesClimate data are available on request from the authors.